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Abstract
OBJECTIVE: To assess the effects of using Chinese
herbs in assisted reproductive technology.
METHODS: Four hundred and thirty-three subjects
aged less than 42 years with infertility due to Fallo-
pian tube or male-related factors who were willing
to undertake in vitro fertilization and embryo trans-
plantation were randomly allocated to a Chinese
herb intervention group (n=216) or a conventional
treatment control group (n=217). All subjects re-
ceived one of four routine ultra-ovulation-promot-
ing therapies at the Reproductive Center in the
Third Hospital Affiliated to Beijing University ac-
cording to their physician's assessments. The sub-
jects in the intervention group received various Chi-
nese herbs depending on their conventional treat-
ment. Endometrial thickness, number of acquired
eggs, and rates of normal fertility, high-quality em-
bryos, biochemical and clinical pregnancy of sub-
jects were assessed in both groups.
RESULTS: The high-quality embryo rate of 51.9% ,
biochemical pregnancy rate of 51.0%, clinical preg-
nancy rate of 44.2% and endometrial thickness of
(10.84±1.75) mm in the intervention group were all
significantly higher than those in the control group
[48.7%, 38.9%, 34.8%, and (10.52±1.50) mm, respec-
tively; P<0.05]. The normal fertility rate of 58.5% in
the Chinese herb group was also significantly supe-
rior to the 54.7% achieved in the control group (P<
0.01). There were no statistically significant differ-
ences (P>0.05) in the average number of acquired
eggs within a single cycle, incidence of excessive
stimulation of ovary, rates of embryo transplanta-
tion or early abortion and birth of living babies be-
tween the two groups.
CONCLUSION: Our findings indicate that Chinese
herbs increase endometrial thickness, improve the
quality of fertility and embryo, and promote embry-
onic nidation, thus enhancing the success rate of in
vitro fertilization/intracytoplasmic sperm injec-
tion-embryo transplantation cycle. Using Chinese
herbs improves the outcomes and safety of assist-
ed reproductive technologies.
© 2014 JTCM. All rights reserved.
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INTRODUCTION
In vitro fertilization and embryo transplantation (IVF-
ET) and the techniques derived from them are the ma-
267
JTCM |www. journaltcm. com June 15, 2014 |Volume 34 | Issue 3 |
Guo J et al. / Clinical Study
jor components of assisted reproductive technology
(ART) and have been important means of treating in-
fertility for more than 30 years. Although the technolo-
gy is continually being improved, the pregnancy rate in
a single IVF-ET cycle is still only 20%-35% . Thus,
many women who are infertile require numerous cy-
cles, which confer enormous mental pressure and a
heavy economic burden on them. To further enhance
the success rate, Traditional Chinese Medicine and
ART have been increasingly used together in recent
years, with good clinical effect.1-3 At present, many Chi-
nese herb therapies have not been standardized, mak-
ing them unable to be used in ART. This study of sub-
jects with infertility caused by fallopian tube or male
factors undergoing IVF-ET compared randomly select-
ed control subjects with subjects receiving "kidney-
nourishing and cycle-regulating" Chinese herb to sup-
port their IVF-ET cycles, the aims being to assess the
effects of the Chinese herbs and encourage standard-
ized use of Chinese herbs in subjects undergoing ART.
MATERIALS ANDMETHODS
Source of cases
All subjects were attending the Reproductive Center of
the Third Hospital Affiliated to Beijing University be-
tween June 2011 and December 2012.
Criteria for diagnosis of infertility
According to the Handbook for Standardized Check
and Diagnosis of Infertile Couples4 issued by the
World Health Organization, no pregnancy in a year of
normal sexual life after marriage can be diagnosed as in-
fertility. Obstruction of the fallopian tube confirmed
by iodized oil radiographs or peritoneoscopy without
other factors contributing to infertility can be diag-
nosed as "infertility caused by fallopian tube factors".5
Infertility caused by low sperm counts, disorders of the
vas deferens, abnormalities in semen and other male
sexual disorders can be diagnosed as "infertility caused
by male factors".4
Other inclusion criteria
Infertility caused by fallopian tube or male factors and
subject eligible for ART, these requirements compris-
ing age 22-42 years, serum basal follicle-stimulating
hormone (bFSH) on the second day of menstruation
<15I U/L, ratio of bFSH to basal luteal hormone <3.6,
basal antral follicle count on both sides on the second
or third day of menstruation ≥5, and two or fewer pre-
vious ultra-ovulation-promoting cycles.
Exclusion criteria
Infertility caused by congenital physiological defects or
deformities, severe endometriosis, endometriomas and
endometrial polyps, severe hydrosalpinx, genetic and
immune factors, comorbidities such as severe primary
diseases of the cardiovascular system, liver, kidney and
hematopoietic system, psychosis, sensitivity to the
herbs being investigated.
Criteria for eliminating subjects after their
admission to the study
Recognition that subject did not meet inclusion crite-
ria or should have been excluded, consumption of ex-
cessive dosage of study herb (s), particularly if this
strongly influenced the outcomes, subject chose to
withdraw from the study, subject declined prescribed
medication or follow-up tests, subject took ≤50% of
prescribed herb dosage, herb discontinued because of
serious adverse reaction (s).
Ethical considerations
All subjects gave their written informed consent to par-
ticipate in the study. This research was approved by the
Medical Reproductive Ethics Committee of the Third
Hospital Affiliated to Beijing University.
Calculation of required size of samples
According to published reports, the mean clinical preg-
nancy rate after a single cycle of fresh embryo trans-
plantation is 30% .6 After Chinese herb intervention,
the rate is 60%-70%.2,3 However, the sample size was
small. We thought it might be higher then the real. So
we selected 45% as the rate of the expected experimen-
tal subjects according to our experience, When α=0.05
(two-sided) and power=0.80, the calculated result was
that 200 patients were required in each group for elimi-
nation rate about 20% .
Randomized pattern and grouping
Using sealed light-proof randomized envelopes with
computerized serial numbers, subjects were randomly
allocated to control and intervention groups by profes-
sionals at the Epidemiologic Research Center of the
Third Hospital Affiliated to Beijing University. An at-
tending doctor was responsible for case screening and
grouping. The 440 selected cases were randomly allo-
cated to a Chinese herb intervention group and a con-
ventional treatment control group in a ratio of 1∶1.
Four of the subjects allocated to the Chinese herb
group refused randomized distribution and were elimi-
nated, thus 216 subjects entered the intervention arm
of this study. Similarly, three of the subjects allocated
to the control group refused randomized distribution
and were eliminated, thus 217 cases entered the con-
trol arm of this study (Figure 1).
Intervention method
The following four conventional ultra-ovulation-pro-
moting regimens were used according to ovarian re-
serve function: (a): gonadotropin-releasing hormone
(GnRH) agonist long term protocal; (b): GnRH ago-
nist short term protocal; (c): GnRH antagonist proto-
cal (Sizekai); (d): GnRH agonist ultra-long protocal.
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The Chinese herb interventions occurred in two stages
based on the conventional treatment described above.
In the first stage, the ultra-ovulation-promoting stage,
which began on the third day of menstruation, subjects
in the intervention group also took the following Chi-
nese herb ovulation-promoting combination: modified
Erzhi pill and Siwu decoction, which consists of Nu-
zhenzi (Fructus Ligustri Lucidi) 15 g, Mohanlian (Herba
Ecliptae prostratae) 12 g, Gouqizi (Fructus Lycii) 15 g,
Tusizi (Semen Cuscutae) 20 g, Shudihuang (Radix
Rehmanniae Praeparata) 20 g, Shanzhuyu (Fructus Cor-
ni) 15 g, Danggui (Radix Angelicae Sinensis) 10 g,
Baishao (Radix Paeoniae Alba) 12 g, Ziheche (Placenta
Hominis) 15 g and Shanyao (Phizoma Dioscoreae Oppos-
itae) 20 g. Baishao (Radix Paeoniae Alba) was removed
and Baizhu (Rhizoma Atractylodis Macrocephalae) 15 g
added for spleen deficiency and loose stools. Huangqi
(Radix Astragali Mongolici) 15 g was added for Qi defi-
ciency. Huangqin (Radix Scutellariae Baicalensis) 10 g
and Dihuang (Radix Rehmanniae) 15 g were added for
excessive heat and dry mouth. Specially assigned per-
sons were in charge of decocting the herbs. The sub-
jects were supplied with 400 mL sealed packs of medic-
inal liquid and asked to take 200 mL of the decoction
morning and evening for 5 consecutive days. From the
eighth day of menstruation, the subjects took the fol-
lowing Chinese herb number two ovulation-promoting
combination: modified Erxianchuyun decoction and
Siwu decoction, which consists of Xianmao (Rhizoma
Curculiginis) 10 g, Yinyanghuo (Herba Epimedii Brevi-
cornus) 15 g, Bajitian (Radix Morindae Officinalis) 15 g,
Tusizi (Semen Cuscutae) 20 g, Zishiying (Flouritum) 15
g, Shudihuang (Radix Rehmanniae Praeparata) 20 g,
Danggui (Radix Angelicae Sinensis) 15 g and Chuanx-
iong (Rhizoma Chuanxiong) 10 g. Baizhu (Rhizoma
Atractylodis Macrocephalae) 20 g, Dihuang (Radix Rehm-
anniae) 15 g and Beishashen (Radix Glehniae) 15 g were
added for dry throat and constipation. Huangqin (Ra-
dix Scutellariae Baicalensis) 12 g was added for red
tongue, yellow fur and excessive heat. Xiangfu (Rhi-
zoma Cyperi) 10 g and stir-frying Suanzaoren (Semen
Ziziphi Spinosae) 30 g were added for nervousness, anx-
iety, insomnia and vagueness. The methods for decoct-
ing and taking the herbs were as described for the num-
ber one combination. When the subjects had complet-
ed taking the decoction for 5 consecutive days, human
chorionic gonadotropin (Ovidrel 250 μg/suppor, from
the Swiss MerckSerono Company, Geneva, Swiss)
250-500 μg, was subcutanous injected. If it was neces-
sary to extend the duration of HCG treatment, the de-
coction was taken for 2-3 extra days.
In the second stage, the nidation stage, on the day of
Figure 1 Flow chart depicting use of Chinese herbs in stages during IVF-ET
IVF-ET: In vitro fertilization and embryo transplantation.
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transplantation of the embryo, subjects in the interven-
tion group began taking Wenshenantai decoction (for
warming the kidneys and preventing miscarriage),
which consists of Shudihuang (Radix Rehmanniae
Praeparata) 15 g, Tusizi (Semen Cuscutae) 20 g, Ch-
uanxuduan (Radix Dipsaci Asperoidis) 15 g, stir-frying
Duzhong (Cortex Eucommiae) 15 g, Sangjisheng (Her-
ba Taxilli Chinensis) 20 g, Bajitian (Radix Morindae Of-
ficinalis) 15 g, Gouqizi (Fructus Lycii) 15 g, Danshen
(Radix Salviae Miltiorrhizae) 15 g, Huangqin (Radix
Scutellariae Baicalensis) 10 g, Huangqi (Radix Astragali)
15 g and Danggui (Radix Angelicae Sinensis) 10 g. The
herb-decocting method was as described above. The
subjects took the decoction morning and evening for 5
consecutive days, after which they took the same decoc-
tion, but without the Danshen (Radix Salviae Miltior-
rhizae), for a further 7-10 days.
Variables assessed
Endometrial thickness was assessed and typed on the
day of injection of HCG, the number of eggs recorded
after they had been collected, the normal fertility rate
calculated (number of normally fertilized eggs/total
number of eggs collected), and the quality of the trans-
planted embryos morphologically evaluated after the
fertilized eggs had divided into 4-8 cells. Grade Ⅰ and
grade Ⅱ 6 embryos were defined as high-quality em-
bryo. In addition, the high-quality embryo rate (num-
ber of high-quality embryos/number of spontaneously
splitting embryos) were calculated, the number of can-
celled cycles recorded together with the reasons for can-
cellation, the number of OHSS (ovarian hyper-stimula-
tion syndrome) cycles recorded, and the incidence of
cancelled cycles and OHSS cycles calculated. Fourteen
days after embryo transplantation, subjects with serumβ-HCG ≥30 mIU/mL were diagnosed as in biochemi-
cal pregnancy. Thirty days after embryo transplanta-
tion, those in whom fetal hearts were seen on B-ultra-
sonic examination were diagnosed as in clinical preg-
nancy. The biochemical and clinical pregnancy rates,
embryo implantation rate (30 days after embryo trans-
plantation: number of living embryos/total number of
transplanted embryos), early abortion rate (within 12
weeks of pregnancy: number of abortions or embryos
with arrested development/number of clinical pregnan-
cies), the number and incidence of living babies born
were calculated.
Statistical analysis
Statistical software SPSS 19.0 (IBM SPSS Statistics
19.0, Armonk, NY, USA) was used to analyze data. Da-
ta are presented as (mean ± standard deviation). Stu-
dent's t-test was used for independent samples and theχ2 test for enumeration data. The tests were two sided.
P<0.05 was regarded as denoting statistically signifi-
cant differences. Data of all cases were analyzed.
RESULTS
Comparison of baseline characteristics of the two
groups
As shown in Table 1, there were no statistically signifi-
cant differences (P>0.05) between the two groups in
age, body mass index, years of infertility, basal serum
FSH, estradiol and luteinizing hormone concentra-
tions, factors responsible for infertility, ultra-ovula-
tion-promoting regimen and technique of fertilization.
Comparison of endometrial thickness, number of
acquired eggs, fertility rate, embryo-splitting and
embryo quality on the day of injection of HCG
On the day of injection of HCG, the average endome-
trial thickness in the Chinese herb group was (10.84±
1.75) mm and (10.52±1.50) mm in the control group,
this difference being statistically significant (P<0.05).
Item
Age (years, xˉ ±s)
BMI ( xˉ ±s)
Years of infertility ( xˉ ±s)
bFSH (IU/L, xˉ ±s)
bLH (IU/L, xˉ ±s)
bE2 (pmol/L, xˉ ±s)
Primary/secondary [n (%)]
Female factor / male factor / couple [n (%)]
Standard long pattern / short pattern / sizekai
pattern / ultra long pattern [n (%)]
IVF/ICSI [n (%)]
Chinese herb group (n=216)
32.1±4.3
22.1±3.4
4.9±3.4
7.1±2.4
4.3±2.7
151.4±71.6
104 (54.8)/102 (45.2)
105 (48.6) /56 (25.9)/55 (25.5)
122 (56.5 )/ 19 (8.8 )
/ 55(25.4 ) /20 (9.3 )
100 (46.3)/116 (53.7)
Control group (n=217)
31.6±4.3
22.1±3.0
4.9±3.2
6.9±2.1
4.3±3.5
161.0±64.0
106 (53.4)/101 (46.6)
93 (43.9)/66 (30.4)/58 (26.7)
120 (55.3) /21(9.7)
/ 58 (26.7) /18 (8.3 )
107 (49.3)/110 (50.7)
Table 1 Comparison of baseline characteristics in intervention (Chinese herb) and control groups
Notes: BMI: body mass index; bFSH: basal follicle-stimulating hormone; bLH: basal luteinizing hormone; bE2: basal estrogen; IVF: in vi-
tro fertilization; ICSI: intra-cytoplasmic sperm injection. P>0.05, in data of all the items between the two groups.
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There was no statistically significant difference (P>
0.05) in endometrium rate A type (endometrial typical
three line) between the two groups. The normal fertili-
ty rate was 58.5% in the Chinese herb group and
54.7% in the control group, this difference being statis-
tically significant (P=0.003). The high-quality embryo
rate was 52.1% in the Chinese herb group and 48.7%,
this difference being statistically significant (P<0.05).
There were no statistically significant differences be-
tween the two groups (P>0.05) in average number of
acquired eggs, rate of embryo-splitting and cancelled
cycles, and OHSS incidence (Table 2).
Comparison of pregnancy outcomes
The biochemical pregnancy rate was 51.0% and the
clinical pregnancy rate 44.2% in the Chinese herb
group, both being significantly better the 38.9% and
34.8% , respectively, in the control group (P<0.05).
There were no statistically significant differences (P>
0.05) between the two groups in embryo transplanta-
tion rate, early abortion rate, and birth rate of living ba-
bies (Table 3).
Safety of Chinese herbs
Five subjects developed abdominal distension, nausea,
mild diarrhea and frequent of defecation during ovula-
tion-promoting cycles in the Chinese herb group. A
small amount of vaginal hemorrhage occurred in two
subjects; this being a side-effect of the hormonal regi-
men and unrelated to the Chinese herb treatment.
In the Chinese herb group, after embryo transplanta-
tion, one subject developed painfully swollen breasts,
The complaint did not relieve when dropping the de-
coction. We considered it being a side-effect of the hor-
monal regimen. And one diarrhea and one vomiting,
these symptoms were caused by irregular diets unrelat-
ed to the Chinese herbs.
Two weeks after completing a treatment cycle, no ab-
normalities attributable to Chinese herbs were found
on routine blood and urine examination, including he-
patic and renal function tests, in any subject in the Chi-
nese herb group, indicating that these herbs are safe.
Compliance with Chinese herb regimen
In the Chinese herb group, during the ultra-ovula-
tion-promoting stage, five subjects discontinued their
Chinese herb treatment of their own accord because of
mild abdominal distension, nausea, diarrhea or fre-
quent defecation, four discontinued their herbs be-
cause they developed upper respiratory tract infection
or fever, making these herbs inappropriate, and one dis-
continued them because of concern about possible
their adverse effects. After embryo transplantation,
four subjects left the study because of concern about
possible influences of the Chinese herbs on the fetus
and because of their inconvenience.
DISCUSSION
Ultra-ovulation-promoting cycles involve disruption of
the normal hormone environment, thus influencing
the quality of eggs and embryos and fertility and caus-
ing abnormal endometrial development.4
According to Traditional Chinese Medicine, essence is
Item
Endometrial thickness (mm, xˉ ±s)
Endometrium A [n (%)]
Average number of acquired eggs ( xˉ ±s)
Normal fertility rate [n (%)]
High-quality embryo rate [n (%)]
OHSS incidence [n (%)]
Cycle-cancelling rate [n (%)]
Chinese herb group (n=216)
10.84±1.75
192 (88.9)
13.93±7.87
1760 (58.5)
1047 (51.9)
8 (3.7)
11 (5.1)
Control group (n=217)
10.52±1.50
197 (90.8)
13.60±7.29
1615 (54.7)
929 (48.7)
9 (4.1)
21 (9.7)
Statistic value
﹣2.312
0.426
﹣0.519
8.592
4.389
0.023
3.325
P value
0.021
0.514
0.604
0.003
0.036
0.879
0.068
Table 2 Comparison of endometrial characteristics, number of acquired eggs, fertility and embryo quality in the two groups
Note: OHSS: ovarian hyper-stimulation syndrome.
Item
Biochemical pregnancy rate
Clinical pregnancy rate
Embryo transplantation rate
Early abortion rate
Living baby rate
Chinese herb group (n=206)
104 (51.0)
91 (44.2)
98 (20.6)
7 (7.7)
57 (27.7)
Control group (n=198)
77 (38.9)
68 (34.8)
81 (19.0)
4 (5.9)
51 (25.8)
χ2
5.490
4.089
0.369
0.198
0.189
P value
0.019
0.043
0.554
0.656
0.664
Table 3 Comparison of pregnancy outcomes in the two groups [n (%)]
271
JTCM |www. journaltcm. com June 15, 2014 |Volume 34 | Issue 3 |
Guo J et al. / Clinical Study
stored in the kidney, this governs growth, development
and reproduction. Sufficient kidney essence is essential
for ensuring good reproductive function. During ul-
tra-ovulation-promoting cycles, a great deal of kidney
essence is mobilized to enable the follicles to develop
and mature quickly, inevitably causing insufficiency of
kidney essence. This in turn brings about deficiency of
liver blood because "the kidney and the liver have a
common source" and "blood is stored in the liver",
eventually leading to single egg cells receiving insuffi-
cient essence and blood. Therefore, nourishing the kid-
ney and liver and enriching essence and blood can cor-
rect the unbalanced state of the body during the ovula-
tion-promoting stage.
The Chinese herb intervention regimen used in this
study was developed based on a "kidney-nourishing
and cycle-regulating method".7 The growth and devel-
opment of follicles during the menstrual cycle are close-
ly associated with changes in Qi, blood, Yin and Yang
in internal organs. Because "Yin growth" is the main
physiological feature of the third to eighth days of men-
struation, taking a Chinese decoction for nourishing
the kidney, enriching the blood and promoting blood
circulation can boost the development and maturity of
follicles and reinforce kidney essence to enrich the
blood and contribute to endometrial growth. After the
eighth day of menstruation, when a suitably developed
follicle is ready, a Yang-assisting herb is added to pro-
mote the transformation of Yin and Yang, thus en-
abling the follicle to further mature and prepare for
ovulation.
In our study, the rates of normal fertility and
high-quality embryos were significantly higher in the
Chinese herb group than in the control group (P<0.01,
P<0.05, respectively), as has been reported by others. 2,3
In our study, a Chinese decoction was used at the be-
ginning of each controlled ovarian hyperstimulation cy-
cles in the intervention group. Because such brief inter-
ventions clearly cannot alter the number of follicles,
there was no significant difference between the two
groups in the average number of acquired eggs (P>0.05).
Endometrial thickness, an important index of endome-
trial function, is of great significance in predicting en-
dometrial acceptance.8 We found that the endometri-
um was significantly thicker in the Chinese herb group
than in the control group, as has been reported by oth-
ers,9 suggesting that the Chinese herb intervention im-
proved endometrial acceptance during ovulation-pro-
moting cycles. We also found that the incidence of
OHSS and cancelled cycles tended to be lower in the
Chinese herb than in the control group; however, these
differences were not statistically significant. This find-
ing is inconsistent with a report that Chinese herbs can
reduce the incidence of OHSS.10 This apparent dispari-
ty may be attributable to the fact that patients with
polycystic ovaries were excluded from this study:
OHSS occurs more readily in subjects with polycystic
ovaries.
Wenshenantai Yin (a decoction for warming the kid-
ney and preventing miscarriage) mainly comprises
herbs that nourish the kidneys, enrich Qi and promote
blood circulation; it has been used clinically for many
years and is effective.11 Animal experiments have shown
that miscarriage-preventing herbs can regulate the ex-
pression of endometrial heparin-binding epidermal
growth factor and its receptor,12 facilitate development
of endometrial superficial pinosomes13 and promote
generation of endometrial blood vessel, all of which
help nidation of the embryo.14 In this study, the bio-
chemical and clinical pregnancy rates were significant-
ly higher in the Chinese herb group than in the con-
trol group; however, there were no significant differ-
ences between the two groups in rates of embryo
transplantation and early miscarriage. The latter may
be attributable to the brevity of treatment with Chi-
nese herbs. The relationship between cycles of treat-
ment with Chinese herbs and their effects requires
further investigation.
There are few published reports of large studies with
randomly assigned controls using Chinese herbs during
in vitro fertilization and embryo transplantation, either
from China or elsewhere. Our findings have provided
reliable clinical evidence for using Chinese herbs in
ART. We have here presented a safe, standardized and
rational regimen of Chinese herbs to use during IVF/
ICSI-ET and recommend its implementation.
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